Chemed Corporation $CHE Shares Sold by NewEdge Wealth LLC

NewEdge Wealth LLC lowered its stake in Chemed Corporation (NYSE:CHE) by 25.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,221 shares of the company’s stock after selling 1,444 shares during the period. NewEdge Wealth LLC’s holdings in Chemed were worth $1,806,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Smartleaf Asset Management LLC increased its holdings in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the period. First Horizon Corp acquired a new position in shares of Chemed in the third quarter valued at approximately $31,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Chemed in the third quarter valued at approximately $45,000. Danske Bank A S increased its holdings in shares of Chemed by 250.0% in the fourth quarter. Danske Bank A S now owns 140 shares of the company’s stock valued at $60,000 after purchasing an additional 100 shares during the period. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after purchasing an additional 76 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Up 0.7%

Chemed stock opened at $422.71 on Thursday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The firm has a market capitalization of $5.61 billion, a price-to-earnings ratio of 23.04, a price-to-earnings-growth ratio of 1.57 and a beta of 0.54. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $583.96. The stock’s fifty day moving average is $396.27 and its two-hundred day moving average is $425.23.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. The business had revenue of $657.51 million for the quarter, compared to analyst estimates of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter last year, the company earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts predict that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CHE. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Royal Bank Of Canada boosted their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Finally, Wall Street Zen raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $501.50.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.33% of the stock is currently owned by insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.